USA and India sign trade deal

# USA and India Sign Trade Deal ## From Tension to Triumph: Key Takeaways After months of negotiations, President Donald Trump and Prime Minister Narendra Modi announced a landmark **Indo-US trade deal** on February 2, 2026. US tariffs on Indian goods drop from **50% to 18%**, boosting India's export edge over rivals like Indonesia (19%) and Vietnam (20%). Trump shared the news on Truth Social, with Modi responding warmly, signaling stronger strategic ties.[1][2][3] ## Deal Highlights in Points - **Tariff Reduction**: US reciprocal tariffs slashed to **18%** from 25% base + 25% penalty (linked to Russian oil); applies to textiles, garments, shrimps, gems, jewelry—exempts electronics, smartphones, pharma.[1][2][3] - **India's Commitments**: Buy **$500B** in US energy (LNG/oil), tech, agriculture, coal, defense; phase down Russian oil via diversification (private refiners like Reliance flexible).[1][2][4] - **US Market Access**: India cuts tariffs/non-tariff barriers on US goods toward **zero**; limited ag concessions (pulses, walnuts, cranberries, apples)—no GMO/dairy risks.[1][5] - **Sector Wins**: Eases pressure on Indian exporters; strengthens manufacturing, IT, pharma; builds on EU/UK/NZ FTAs for global competitiveness.[3] ## Strategic Wins for India This isn't just tariffs—it's **equilibrium in global trade**. India's patient sequencing (FTAs with EU/UK/NZ) and manufacturing surge (electronics exports up 8x to ₹4L crore) forced US adjustment amid China risks. Energy stays pragmatic: mix US/Russia/ME sources without rupture.[3] ## Investor Implications - **Boosted Sectors**: Exporters like pharma (Sun Pharma), IT (TCS), autos gain US access; electronics/semiconductors resilient. - **Geopolitical Edge**: Counters China; aligns with PLI schemes (₹1.76L crore investments, 1.2M jobs).[3] - **Market Outlook**: Stocks may rally on relief, but watch official texts for details—oil prices dipping already.[1][2] ## Actionable Advice for Your Portfolio - **Prioritize Exporters**: Allocate to quality value plays in pharma/IT/manufacturing for long-term compounding. - **Energy Watch**: Track refiners adapting suppliers; diversify beyond headlines. - **Stay Disciplined**: With 7/10 risk tolerance, focus on fundamentals—patience beats speculation. Verify deal texts before trades. This deal rewards India's strategic autonomy, positioning portfolios for sustained growth in a multipolar world.[1][3]